A carregar...

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?

Myelodysplastic syndrome (MDS) represents a heterogeneous group of diseases with clonal proliferation, bone marrow failure and increasing risk of transformation into an acute myeloid leukaemia. Structured guidelines are developed for selective therapy based on prognostic subgroups, age, and performa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stintzing, Sebastian, Kemmerling, Ralf, Kiesslich, Tobias, Alinger, Beate, Ocker, Matthias, Neureiter, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3100562/
https://ncbi.nlm.nih.gov/pubmed/21629744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/214143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!